651 results match your criteria: "Inner Ear Meniere Disease Medical Treatment"

Allergy and autoinflammation drive persistent systemic inflammatory response in Meniere Disease: A longitudinal study.

Clin Immunol

November 2024

Meniere's Disease Neuroscience Research Program, Faculty of Medicine & Health, School of Medical Sciences, The Kolling Institute, The University of Sydney, Sydney, New South Wales, Australia; Division of Otolaryngology, Department of Surgery, Instituto de Investigación Biosanitaria, ibs.GRANADA, Granada, Universidad de Granada, Granada, Spain; Sensorineural Pathology Programme, Centro de Investigación Biomédica en Red en Enfermedades Raras, CIBERER, Madrid, Spain.

Article Synopsis
View Article and Find Full Text PDF

Objective: To use animal pharmacokinetic data and FluidSIM modeling to estimate human dexamethasone perilymph concentrations from plasma concentration measurements over time following a single intratympanic administration of SPT-2101.

Study Design: Perilymph and plasma dexamethasone concentrations were measured in guinea pigs and African green monkeys over 3 to 6 weeks post-intratympanic administration of SPT-2101. Plasma concentrations of dexamethasone were measured in Ménière's disease patients post-intratympanic administration of SPT-2101.

View Article and Find Full Text PDF

IL-1β promotes glutamate excitotoxicity: indications for the link between inflammatory and synaptic vesicle cycle in Ménière's disease.

Cell Death Discov

November 2024

Department of Otolaryngology-Head and Neck Surgery, Shandong Provincial ENT Hospital, Shandong University, Jinan, Shandong, China.

Ménière's disease (MD) is a complex inner ear disorder characterized by a range of symptoms, with its pathogenesis linked to immune-related mechanisms. Our previous research demonstrated that IL-1β maturation and release can trigger cell pyroptosis, exacerbating the severity of the endolymphatic hydrops in a mouse model; however, the specific mechanism through which IL-1β influences MD symptoms remains unclear. This study conducted on patients with MD examined changes in protein signatures in the vestibular end organs (VO) and endolymphatic sac (ES) using mass spectrometry.

View Article and Find Full Text PDF

Objective: Betahistine is a partial H1 receptor agonist and a potent H3 receptor antagonist commonly used for the treatment of MD and peripheral vertigo. The aim of this study was to investigate the impact of betahistine on the salt induced cytokine expression profiles of AIED and MD patients.

Methods: Peripheral blood mononuclear cells (PBMCs) were obtained from 24 patients with autoimmune inner ear disease (AIED) or Meniere's disease (MD) during an acute exacerbation of hearing loss.

View Article and Find Full Text PDF
Article Synopsis
  • Dizziness often leads to complicated diagnosis processes, requiring patients to see multiple specialists and imposing challenges on health services; early and accurate diagnosis could help alleviate these issues.
  • The CAVA trial is a multicentre study aiming to assess a new diagnostic device that distinguishes between three common inner-ear causes of dizziness: Ménière's disease, vestibular migraine, and benign paroxysmal positional vertigo, involving 255 participants in the UK.
  • The CAVA device collects eye movement data using specialized sensor arrays, with goals to create a reliable algorithm for diagnosis, evaluate financial and health benefits for the NHS, and facilitate the device's deployment in the healthcare system.
View Article and Find Full Text PDF

Semicircular canal and vestibular plugging in patients with Meniere's disease: a preliminary study.

Acta Otolaryngol

October 2024

Department of Otolaryngology-Head and Neck Surgery, Shandong Provincial ENT Hospital, Shandong University, Jinan, China.

Article Synopsis
  • A study aimed to evaluate the safety and effectiveness of simultaneous semicircular canal and vestibular plugging for treating patients with intractable Meniere's disease suffering from vertigo and drop attacks.
  • Five patients were observed over six months post-surgery; none experienced recurring drop attacks, and four had no vertigo episodes, indicating promising results.
  • The procedure shows potential in alleviating symptoms of Meniere's disease while maintaining hearing function, but more research is needed to validate these findings.
View Article and Find Full Text PDF

The clinical manifestation and treatment of Meniere's Disease from the viewpoint of the water homeostasis of the inner ear.

Auris Nasus Larynx

September 2024

Department of Otolaryngology-Head & Neck Surgery, Kobe University, Graduate School of Medicine, Hyogo, Japan. Electronic address:

Endolymphatic hydrops, a pathological feature of Ménière's disease, has been experimentally and clinically confirmed to be influenced by the blood circulation of vasopressin (VP). VP is a well-known hormonal regulator of water homeostasis. In addition, VP is influenced by various environmental changes, dehydration, fluctuation of atmospheric pressure, pregnancy, and other factors.

View Article and Find Full Text PDF

Efficacy of endolymphatic duct blockage in treating Ménières disease.

Zhong Nan Da Xue Xue Bao Yi Xue Ban

May 2024

Department of Otolaryngology-Head and Neck Surgery, Second Xiangya Hospital, Central South University, Changsha 410011.

Article Synopsis
  • Ménière's disease (MD) is an inner ear disorder causing vertigo, hearing loss, tinnitus, and ear fullness, primarily treated through endolymphatic sac (ES)-related surgery for patients not responding to medications.
  • This study analyzed 33 patients who underwent endolymphatic duct blockage (EDB) surgery, comparing outcomes based on the morphology of their ES (normal vs. atrophic types).
  • Results showed that patients with normal-type ES had significantly better control of vertigo and improved cochlear function, along with a notable reversal of endolymphatic hydrops, indicating different disease mechanisms between the two types.
View Article and Find Full Text PDF

Objectives: The aim was to evaluate endolymphatic hydrops in patients with severe Ménière's disease (MD) before and after vestibular neurectomy to verify if vestibular denervation results in hydrops regression.

Methods: Magnetic resonance imaging was performed after intravenous gadolinium injection in twenty patients with unilateral definite MD before and after the vestibular neurectomy. Clinical symptoms and audiovestibular tests were evaluated.

View Article and Find Full Text PDF

Retrolabyrinthine Bone Thickness as a Radiologic Marker for the Hypoplastic Endotype in Menière Disease.

AJNR Am J Neuroradiol

September 2024

Department of Otolaryngology-Head and Neck Surgery (S.D.R., A.H.E.), Massachusets Eye and Ear, Harvard Medical School, Boston, Massachusetts.

Article Synopsis
  • - The study focuses on Menière disease (MD), which has two main types: one with an underdeveloped endolymphatic sac (MD-hp) and another with a normally developed sac that deteriorates (MD-dg). Understanding which type a patient has is crucial for predicting disease progression and guiding treatment.
  • - Researchers analyzed CT scans of 32 patients with definite MD and 33 healthy controls to measure the angular trajectory of the vestibular aqueduct (ATVA) and the thickness of the surrounding bone, looking for correlations that could help in differentiating MD types.
  • - Results indicated that patients with MD-hp had significantly thinner retrolabyrinthine bone compared to those with MD-dg, suggesting a
View Article and Find Full Text PDF
Article Synopsis
  • Meniere's disease is an inner ear disorder that requires accurate diagnosis, but current testing with the ECochG test lacks sensitivity, prompting the inclusion of complementary tests like the SVV test.
  • A study involving 53 patients looked at using the SVV test in both static and dynamic modes along with the ECochG test to better identify Meniere's disease and assess its effectiveness.
  • The results indicated that the SVV test has a cutoff point of 2.1 degrees with moderate sensitivity and specificity, suggesting that it should not be solely relied upon for diagnosis and that further testing is necessary.
View Article and Find Full Text PDF
Article Synopsis
  • Glucocorticoids (GC) are commonly used to treat various ear and sinus disorders, but many patients experience resistance to these treatments.
  • The exact mechanisms behind GC resistance are not well understood, leading to ongoing research in this area.
  • This paper reviews both GC receptor and non-receptor factors contributing to resistance, aiming to provide insights for developing alternative treatment options in the future.
View Article and Find Full Text PDF

[Vertigo and dizziness in child: a clinical analysis in 120 cases].

Zhonghua Nei Ke Za Zhi

July 2024

Department of Otorhinolaryngology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.

Article Synopsis
  • The study analyzed 120 children diagnosed with vertigo in a Beijing hospital over a four-year period, focusing on the disease composition, symptoms, diagnosis, and treatment.
  • The main causes of vertigo identified included vestibular migraine of childhood, recurrent vertigo, and secretory otitis media, with variations in prevalence among different age groups.
  • The findings highlight the importance of using age-appropriate examination techniques and addressing the mental health of both children and their parents during treatment.
View Article and Find Full Text PDF

Characterising inner ear disorders represents a significant challenge due to a lack of reliable experimental procedures and identified biomarkers. It is also difficult to access the complex microenvironments of the inner ear and investigate specific pathological indicators through conventional techniques. Omics technologies have the potential to play a vital role in revolutionising the diagnosis of ear disorders by providing a comprehensive understanding of biological systems at various molecular levels.

View Article and Find Full Text PDF

Background: Although various medical remedies have been attempted to alleviate the symptoms of Meniere's disease (MD), the risk-benefit ratios of these various treatments remain debatable.

Objective: We investigated the efficacy of sound stimulation of 100 Hz for treating vestibular dysfunction in patients with Meniere's disease (MD).

Materials And Methods: Patients with definitive MD with intractable vestibular symptoms and endolymphatic hydrops (EH) in the inner ear were evaluated.

View Article and Find Full Text PDF

[Psychosomatic medicine for patients with Meniere's disease].

HNO

May 2024

Tinnitus Klinik Dr. Hesse am Krankenhaus Bad Arolsen, Große Allee 50, 34454, Bad Arolsen, Deutschland.

Background: Unpredictable attacks of vertigo with or without emesis, unilateral hearing loss, and tinnitus characterize the inner ear disorder that is classified as part of Meniere's disease (MD). While the pathological final stage with cochleovestibular hydrops seems to be certain as a component of MD, there are many uncertainties with respect to the multifactorial pathogenesis. It is certain that the disease can have effects in addition to the attack, which questions the treatment of things that were previously taken for granted.

View Article and Find Full Text PDF

Objective: To investigate the safety and feasibility of precise delivery of a long-acting gel formulation containing 6% dexamethasone (SPT-2101) to the round window membrane for the treatment of Menière's disease.

Study Design: Prospective, unblinded, cohort study.

Setting: Tertiary care neurotology clinic.

View Article and Find Full Text PDF

Sound Exposure Promotes Intratympanic Drug Delivery to the Inner Ear.

Otolaryngol Head Neck Surg

October 2024

Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

Objective: To investigate the impact of sound exposure, with the resultant windows vibration on perilymphatic concentrations following intratympanic (IT) dexamethasone and gentamicin in an animal model.

Study Design: Animal model blinded study.

Setting: Animal facility of a tertiary medical center.

View Article and Find Full Text PDF

Introduction: We present a series of six cases whose clinical presentations exhibited audiovestibular manifestations of a third mobile window mechanism, bearing a reasonable resemblance to Ménière's disease and otosclerosis. The occurrence of these cases in such a short period has prompted a review of the underlying causes of its development. Understanding the pathophysiology of third mobile window syndrome and considering these entities in the differential diagnosis of conditions presenting with vertigo and hearing loss with slight air-bone gaps is essential for comprehending this group of pathologies.

View Article and Find Full Text PDF

Vestibular neurectomy is an effective method eliminating vertigo attacks in patients suffering from disabling Meniere's disease with no clinical improvement despite conservative and intratympanic therapy. Magnetic resonance imaging allows in vivo evaluation of changes manifesting in the inner ear after treatment; however, downgrading of the endolymphatic hydrops after vestibular neurectomy had not been previously described in the literature. In the present article, a case of a patient with unilateral severe Meniere's disease treated with selective vestibular nerve section from middle fossa approach was described.

View Article and Find Full Text PDF

Various inner ear diseases such as sensorineural deafness and Meniere's disease bring about problems such as speech communication disorders and decreased work efficiency, which seriously affect the life quality of patients. Due to the special anatomical structure and blood-labyrinth barrier in the inner ear, the current drug administration methods are often unable to achieve satisfactory results. Nanocarriers are the forefront and hot spot of nanotechnology research.

View Article and Find Full Text PDF

This narrative review examines the role of vitamin D as a biomarker in ear disorders, including benign paroxysmal positional vertigo (BPPV), otitis media, bell's palsy, Meniere's disease, and hearing loss. PubMed, The Cochrane Library, and Google Scholar were utilized to conduct a comprehensive literature search, and findings were combined from studies from 2014 to 2024. As highlighted in this review, there is a consistent association between vitamin D deficiency and an increased risk and recurrence of disease especially in BPPV and otitis media.

View Article and Find Full Text PDF

Hypothesis: Proteins enriched in the perilymph proteome of Meńier̀e disease (MD) patients may identify affected cell types. Utilizing single-cell transcriptome datasets from the mammalian cochlea, we hypothesize that these enriched perilymph proteins can be localized to specific cochlear cell types.

Background: The limited understanding of human inner ear pathologies and their associated biomolecular variations hinder efforts to develop disease-specific diagnostics and therapeutics.

View Article and Find Full Text PDF

Preliminary Evidence for the Effects of Gentamicin on Vertical Semicircular Canals.

ORL J Otorhinolaryngol Relat Spec

June 2024

Department of Otorhinolaryngology-Head & Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Introduction: Gentamicin is a vestibulotoxic antibiotic often used in patients with Ménière's disease for its vestibular ablative effects. Gentamicin's effect on the horizontal semicircular canal does not always correlate with the degree of vertigo control achieved by patients; its effect on the vertical semicircular canals remains unknown. We sought to examine the effect of intratympanic gentamicin on vertical semicircular canal function in patients with Ménière's disease using video head impulse testing.

View Article and Find Full Text PDF